Determinants of human papillomavirus coinfections among montreal university students: The influence of behavioral and biologic factors

Cancer Epidemiology Biomarkers and Prevention

Volumn 23, Issue 5, 2014, Pages 812-822

  Smith, Michaela A ^a   Tellier, Pierre Paul ^b   Roger, Michel ^c   Coutlée, Francois ^b,c   Franco, Eduardo L ^b   Richardson, Harriet ^a  

^a QUEEN S UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HLA DQB1 ANTIGEN; HLA G ANTIGEN; BIOLOGICAL FACTOR; VIRUS DNA;

ADULT; ALLELE; ARTICLE; COHORT ANALYSIS; FEMALE; FOLLOW UP; HLA SYSTEM; HLA TYPING; HUMAN; IMMUNE RESPONSE; INFECTION RISK; MAJOR CLINICAL STUDY; MIXED INFECTION; PAPILLOMAVIRUS INFECTION; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEXUAL BEHAVIOR; UNIVERSITY STUDENT; WART VIRUS; CANADA; GENETICS; ISOLATION AND PURIFICATION; PAPILLOMA VIRUS; PAPILLOMAVIRUS INFECTIONS; PROGNOSIS; PSYCHOLOGY; RISK FACTOR; SEXUALITY; STATISTICS AND NUMERICAL DATA; STUDENT; TUMOR VIRUS INFECTIONS; UNIVERSITY; VIROLOGY; YOUNG ADULT;

ADULT; BIOLOGICAL FACTORS; CANADA; COINFECTION; DNA, VIRAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; SEXUAL BEHAVIOR; SEXUAL PARTNERS; STUDENTS; TUMOR VIRUS INFECTIONS; UNIVERSITIES; YOUNG ADULT;

EID: 84899765209     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-13-1255     Document Type: Article

References (46)

1. Vaccarella S, Franceschi S, Snijders PJ, Herrero R, Meijer CJ, Plummer M. Concurrent infection with multiple human papillomavirus types: pooled analysis of the IARC HPV Prevalence Surveys. Cancer Epidemiol Biomark Prev 2010;19: 503-10.
2. Thomas KK, Hughes JP, Kuypers JM, Kiviat NB, Lee SK, Adam DE, et al. Concurrent and sequential acquisition of different genital human papillomavirus types. J Infect Dis 2000;182: 1097-102.
3. Méndez F, Muñoz N, Posso H, Molano M, Moreno V, van den Brule AJ, et al. Cervical coinfection with human papillomavirus (HPV) types and possible implications for the prevention of cervical cancer by HPV vaccines. J Infect Dis 2005;192: 1158-65.
4. Chaturvedi AK, Myers L, Hammons AF, Clark RA, Dunlap K, Kissinger PJ, et al. Prevalence and clustering patterns of human papillomavirus genotypes in multiple infections. Cancer Epidemiol Biomark Prev 2005;14: 2439-45.
5. Liaw KL, Hildesheim A, Burk RD, Gravitt P, Wacholder S, Manos MM, et al. A prospective study of human papillomavirus (HPV) type 16 DNA detection by polymerase chain reaction and its association with acquisition and persistence of other HPV types. J Infect Dis 2001; 183: 8-15.
6. Plummer M, Schiffman M, Castle PE, Maucort-Boulch D, Wheeler CM. A 2-year prospective study of human papillomavirus persistence among women with a cytological diagnosis of atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesion. J Infect Dis 2007;195: 1582-9.
7. Plummer M, Vaccarella S, Franceschi S. Multiple human papillomavirus infections: the exception or the rule? J Infect Dis 2011;203: 891-3.
8. Chaturvedi AK, Katki HA, Hildesheim A, Rodríguez AC, Quint W, Schiffman M, et al. Human papillomavirus infection with multiple types: pattern of coinfection and risk of cervical disease. J Infect Dis 2011; 203: 910-20.
9. Rousseau MC, Villa LL, Costa MC, Abrahamowicz M, Rohan TE, Franco E. Occurrence of cervical infection with multiple human papillomavirus types is associated with age and cytologic abnormalities. Sex Transm Dis 2003;30: 581-7.
10. Fife KH, Cramer HM, Schroeder JM, Brown DR. Detection of multiple human papillomavirus types in the lower genital tract correlates with cervical dysplasia. J Med Virol 2001;64: 550-9.
11. Trottier H, Mahmud S, Costa MC, Sobrinho JP, Duarte-Franco E, Rohan TE, et al. Human papillomavirus infections with multiple types and risk of cervical neoplasia. Cancer Epidemiol Biomark Prev 2006;15: 1274-80.
12. Trottier H, Mahmud S, Prado JCM, Sobrinho JS, Costa MC, Rohan TE, et al. Type-specific duration of human papillomavirus infection: implications for human papillomavirus screening and vaccination. J Infect Dis 2008;197: 1436-47.
13. van der Graaf Y, Molijn A, Doornewaard H, Quint W, van Doorn LJ, van den Tweel J. Human papillomavirus and the long-term risk of cervical neoplasia. Am J Epidemiol 2002;156: 158-64.
14. Moscicki AB, Ma Y, Jonte J, Miller-Benningfield S, Hanson E, Jay J, et al. The role of sexual behavior and human papillomavirus persistence in predicting repeated infections with new human papillomavirus types. Cancer Epidemiol Biomark Prev 2010;19: 2055-65.
15. Ho GY, Studentsov Y, Hall CB, Bierman R, Beardsley L, Lempa M, et al. Risk factors for subsequent cervicovaginal human papillomavirus (HPV) infection and the protective role of antibodies to HPV-16 virus-like particles. J Infect Dis 2002;186: 737-42.
16. Nielsen A, Kjaer SK, Munk C, Iftner T. Type-specific HPV infection and multiple HPV types: prevalence and risk factor profile in nearly 12,000 younger and older Danish women. Sex Transm Dis 2008; 35: 276-82.
17. Rousseau MC, Abrahamowicz M, Villa LL, Costa MC, Rohan TE, Franco EL. Predictors of cervical coinfection with multiple human papillomavirus types. Cancer Epidemiol Biomark Prev 2003;12: 1029-37.
18. Molano M, Posso H, Weiderpass E, Van den Brule A, Ronderos M, Franceschi S, et al. Prevalence and determinants of HPV infection among Colombian women with normal cytology. Br J Cancer 2002; 87: 324-33.
19. Lazcano-Ponce E, Herrero R, MUnoz N, Cruz A, Shah KV, Alonso P, et al. Epidemiology of HPV infection among Mexican women with normal cervical cytology. Int J Cancer 2001;91: 412-20.
20. Levi JE, Fernandes S, Tateno AF, Motta E, Lima LP, Eluf-Neto J, et al. Presence of multiple human papillomavirus types in cervical samples from HIV-infected women. Gynecol Oncol 2004;92: 225-31.
21. Levi JE, Kleter B, Quint WG, Fink MC, Canto CL, Matsubara R, et al. High prevalence of human papillomavirus (HPV) infections and high frequency of multiple HPV genotypes in human immunodeficiency virus-infected women in Brazil. J Clin Microbiol 2002;40: 3341-5.
22. Clifford GM, Goncalves MAG, Franceschi S. Human papillomavirus types among women infected with HIV: a meta-analysis. AIDS 2006; 20: 2337-44.
23. Cervantes JL. Multiple human papillomavirus infection: don't forget the genetic background. J Infect Dis 2011;204: 1816.
24. de Araujo Souza PS, Sichero L, Maciag PC. HPV variants and HLA polymorphisms: the role of variability on the risk of cervical cancer. Future Oncol 2009;5: 359-70.
25. Delves PJ, Roitt I. The immune system: first of two parts. N Engl J Med 2000;343: 37-49.
26. Hildesheim A, Wang SS. Host and viral genetics and risk of cervical cancer: a review. Virus Res 2002;89: 229-40.
27. Mahmud SM, Robinson K, Richardson H, Tellier PP, Ferenczy AS, Roger M, et al. HLA polymorphisms and cervical human papillomavirus infection in a cohort of Montreal University students. J Infect Dis 2007;196: 82-90.
28. Ferguson R, Ramanakumar AV, Richardson H, Tellier PP, Coutlée F, Franco EL, et al. Human leukocyte antigen (HLA)-E and HLA-G polymorphisms in human papillomavirus infection susceptibility and persistence. Hum Immunol 2011;72: 337-41.
29. Metcalfe S, Roger M, Faucher MC, Coutlée F, Franco EL, Brassard P. The association between human leukocyte antigen (HLA)-G polymorphisms and human papillomavirus (HPV) infection in Inuit women of northern Quebec. Hum Immunol 2013;74: 1610-5.
30. Maciag PC, Schlecht NF, Souza PS, Rohan TE, Franco EL, Villa LL. Polymorphisms of the human leukocyte antigen DRB1 and DQB1 genes and the natural history of human papillomavirus infection. J Infect Dis 2002;186: 164-72.
31. Simoes RT, Goņcalves MAG, Castelli EC, Júnior CM, Bettini JS, Discorde ML, et al. HLA-G polymorphisms in women with squamous intraepithelial lesions harboring human papillomavirus. Mod Pathol 2009;22: 1075-82.
32. Ferguson R, Ramanakumar AV, Koushik A, Coutlée F, Franco E, Roger M. Human leukocyte antigen G polymorphism is associated with an increased risk of invasive cancer of the uterine cervix. Int J Cancer 2012;131:E312-E9.
33. Trottier H, Franco EL. The epidemiology of genital human papillomavirus infection. Vaccine 2006;24:S4-S15.
34. Richardson H, Abrahamowicz M, Tellier PP, Kelsall G, du Berger R, Ferenczy A, et al. Modifiable risk factors associated with clearance of type-specific cervical human papillomavirus infections in a cohort of university students. Cancer Epidemiol Biomark Prev 2005;14: 1149-56.
35. Richardson H, Kelsall G, Tellier P, Voyer H, Abrahamowicz M, Ferenczy A, et al. The natural history of type-specific human papillomavirus infections in female university students. Cancer Epidemiol Biomark Prev 2003;12: 485-90.
36. Hosmer DW, Lemeshow S. Model-building strategies and methods for logistic regression. In Applied Logistic Regression. Hoboken, NJ: John Wiley & Sons, Inc.; 2000. p. 91-142.
37. Goodman MT, Shvetsov YB, McDuffie K, Wilkens LR, Zhu X, Thompson PJ, et al. Prevalence, acquisition, and clearance of cervical human papillomavirus infection among women with normal cytology: Hawaii Human Papillomavirus Cohort Study. Cancer Res 2008;68: 8813-24.
38. Rouas-Freiss N, Moreau P, Menier C, Carosella ED. HLA-G in cancer: a way to turn off the immune system. Semin Cancer Biol 2003: 325-36.
39. Wang SS, Hildesheim A. Viral and host factors in human papillomavirus persistence and progression. JNCI Monogr 2003;2003: 35-40.
40. Clements CS, Kjer-Nielsen L, Kostenko L, Hoare HL, Dunstone MA, Moses E, et al. Crystal structure of HLA-G: a nonclassical MHC class I molecule expressed at the fetal-maternal interface. Proc Natl Acad Sci U S A 2005;102: 3360-5.
41. Nielson CM, Harris RB, Flores R, Abrahamsen M, Papenfuss MR, Dunne EF, et al. Multiple-type human papillomavirus infection in male anogenital sites: prevalence and associated factors. Cancer Epidemiol Biomark Prev 2009;18: 1077-83.
42. Vaccarella S, Franceschi S, Herrero R, Muñoz N, Snijders PJ, Clifford GM, et al. Sexual behavior, condom use, and human papillomavirus: pooled analysis of the IARChuman papillomavirus prevalence surveys. Cancer Epidemiol Biomark Prev 2006;15: 326-33.
43. Manhart LE, Koutsky LA. Do condoms prevent genital HPV infection, external genital warts, or cervical neoplasia?: a meta-analysis. Sex Transm Dis 2002;29: 725-35.
44. Green J, De Gonzalez AB, Smith Jaa, Franceschi S, Appleby P, Plummer M, et al. Human papillomavirus infection and use of oral contraceptives. Br J Cancer 2003;88: 1713-20.
45. Vaccarella S, Herrero R, Dai M, Snijders PJ, Meijer CJ, Thomas JO, et al. Reproductive factors, oral contraceptive use, and human papillomavirus infection: pooled analysis of the IARC HPV prevalence surveys. Cancer Epidemiol Biomark Prev 2006;15: 2148-53.
46. Sharkey DJ, Tremellen KP, Jasper MJ, Gemzell-Danielsson K, Robertson SA. Seminal fluid induces leukocyte recruitment and cytokine and chemokine mRNA expression in the human cervix after coitus. J Immunol 2012;188: 2445-54.